Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 ( Br. J. Haematol . 2012; 157: 47–58): use of direct acting oral anticoagulants-Reference-Cited by-同舟云学术

Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 ( Br. J. Haematol . 2012; 157: 47–58): use of direct acting oral anticoagulants

Published:2020-01-13 Issue:2 Volume:189 Page:212-215
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Arachchillage Deepa R. J.¹²^ORCID,Gomez Keith³,Alikhan Raza⁴^ORCID,Anderson Julia A. M.⁵,Lester Will⁶^ORCID,Laffan Mike¹²^ORCID,

Affiliation:

1. Department of Haematology Imperial College Healthcare NHS Trust London UK

2. Centre for Haematology Imperial College London London UK

3. Katherine Dormandy Haemophilia Centre and Thrombosis Unit Royal Free London NHS Foundation Trust London UK

4. Haemophilia and Thrombosis Centre University Hospital of Wales Cardiff UK

5. Department of Haematology Royal Infirmary of Edinburgh Edinburgh UK

6. Centre for Clinical Haematology University Hospitals Birmingham NHS Foundation Trust Birmingham UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16308

Reference15 articles.

1. Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature

2. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

3. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

4. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

5. A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC‐Remove

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline;British Journal of Haematology;2024-09-02

2. Dilemmas in the diagnosis and management of antiphospholipid syndrome;Journal of Thrombosis and Haemostasis;2024-08

3. Thrombotic antiphospholipid syndrome: From guidelines to clinical management;Medicina Clínica;2024-08

4. Characteristics and prognosis of elderly-onset antiphospholipid syndrome: An observational cohort study;Lupus;2024-07-21

5. Guidelines on the investigation and management of antiphospholipid syndrome;British Journal of Haematology;2024-07-19